Research in Washington
- 1 of 3
- next ›
Biopharmaceutical research companies are conducting or have conducted more than 3,600 clinical trials of new medicines in collaboration with the state’s clinical research centers, university medical schools and hospitals (1999 to present).
Of the more than 3,600 clinical trials, more than 2,000 target the nation’s six most debilitating chronic diseases—asthma, cancer, diabetes, heart disease, mental illnesses and stroke.